Tau Screening Study in Patients With Early Symptomatic AD
Public ClinicalTrials.gov record NCT03322462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD
Study identification
- NCT ID
- NCT03322462
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Avid Radiopharmaceuticals
- Industry
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Interventions
- Flortaucipir F18 Drug
- Brain PET Scan Procedure
Drug · Procedure
Eligibility (public fields only)
- Age range
- 60 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2017
- Primary completion
- Aug 30, 2018
- Completion
- Aug 30, 2018
- Last update posted
- Aug 23, 2020
2017 – 2018
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Research Network | San Diego | California | 92103 | — |
| Syrentis Clinical Research | Santa Ana | California | 92705 | — |
| Brain Matters Research | Delray Beach | Florida | 33445 | — |
| Bioclinica (Compass Research) | Orlando | Florida | 32806 | — |
| Axiom Clinical Research | Tampa | Florida | 33609 | — |
| Boston Center for Memory | Newton | Massachusetts | 02459 | — |
| PMG Research | Winston-Salem | North Carolina | 27103 | — |
| Abington Neurological Associates | Willow Grove | Pennsylvania | 19090 | — |
| The Memory Clinic | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03322462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03322462 live on ClinicalTrials.gov.